Journal
TRENDS IN CARDIOVASCULAR MEDICINE
Volume 28, Issue 3, Pages 187-197Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcm.2017.08.015
Keywords
Systemic lupus erythematosus; Lupus; Heart failure; Cardiovascular risk factors
Categories
Ask authors/readers for more resources
Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by a constellation of cardiovascular (CV) and non-CV manifestations. Even though CV complications such as accelerated atherosclerosis and elevated risk of myocardial infarction (MI) have been recognized for many years, there is limited evidence regarding SLE and its association with heart failure (HF). Traditional risk factors of atherosclerotic CV disease, as well as various SLE manifestations and therapies, independently or together, increase the risk of HF in this population. There is a need for sufficiently powered intervention studies focusing on specific risk factors to improve CV outcomes in SLE patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available